XML 38 R19.htm IDEA: XBRL DOCUMENT
v2.4.0.8

STOCKHOLDERS' EQUITY (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2014
STOCKHOLDERS' EQUITY [Abstract] |
Schedule of Stock Option Activity |
|  | Nine months ended March 31, 2014 (Unaudited) |
|  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Terms (in years) |  |  | Aggregate Intrinsic Value Price |
Options outstanding at beginning of period |  |  | 1,958,156 |  |  | $ | 4.01 |  |  |  |  |  |  |
Options exercised |  |  | (15,000 | ) |  | $ | 0.83 |  |  |  |  |  |  |
Options forfeited |  |  | (81,057 | ) |  | $ | 11.59 |  |  |  |  |  |  |
Options outstanding at end of the period |  |  | 1,862,099 |  |  | $ | 3.73 |  |  |  | 3.37 |  |  | $ | 1,461 |
Options exercisable at the end of the period |  |  | 1,862,099 |  |  | $ | 3.73 |  |  |  | 3.37 |  |  | $ | 1,461 |
Options vested |  |  | 1,862,099 |  |  | $ | 3.73 |  |  |  | 3.37 |  |  | $ | 1,461 |
Schedule of Stock Option and Warrant Activity |
|  | Nine months ended March 31, 2014 (Unaudited) |
|  | Number |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Terms (in years) |  |  | Aggregate Intrinsic Value Price |
Options and warrants outstanding at beginning of period |  |  | 315,500 |  |  | $ | 4.40 |  |  |  |  |  |  |
Options granted |  |  | 3,000 |  |  | $ | 0.00 |  |  |  |  |  |  |
Options and warrants exercised |  |  | (16,500 | ) |  | $ | 1.74 |  |  |  |  |  |  |
Options and warrants outstanding at end of the period |  |  | 302,000 |  |  | $ | 4.54 |  |  |  | 3.52 |  |  | $ | 535 |
Options and warrants exercisable at the end of the period |  |  | 300,000 |  |  | $ | 4.54 |  |  |  | 3.45 |  |  | $ | 528 |
Options and warrants vested and expected to vest |  |  | 302,000 |  |  | $ | 4.54 |  |  |  | 3.52 |  |  | $ | 535 |
Options and warrants [Member] |
Stockholders Equity Note [Line Items] |
Schedule of Stock-based Compensation Expenses |
|  | Nine months ended March 31, |  |  | Three months ended March 31, |
|  | 2014 |  |  | 2013 |  |  | 2014 |  |  | 2013 |
Research and development expenses |  | $ | 7 |  |  | $ | - |  |  | $ | 7 |  |  | $ | - |
General and administrative expenses |  |  | - |  |  |  | 24 |  |  |  | - |  |  |  | 3 |
|  | $ | 7 |  |  | $ | 24 |  |  | $ | 7 |  |  | $ | 3 |
Restricted stock units [Member] |
Stockholders Equity Note [Line Items] |
Schedule of Unvested Restricted Stock Units |
|  | Number |
Unvested at the beginning of period |  |  | 1,660,525 |
Granted |  |  | 1,224,908 |
Forfeited |  |  | (34,979 | )
Vested |  |  | (936,299 | )
Unvested at the end of the period |  |  | 1,914,155 |
Expected to vest after March 31, 2014 |  |  | 1,872,940 |
Schedule of Stock-based Compensation Expenses |
|  | Nine months ended March 31, |  |  | Three months ended March 31, |
|  | 2014 |  |  | 2013 |  |  | 2014 |  |  | 2013 |
Research and development expenses |  | $ | 656 |  |  | $ | 573 |  |  | $ | 442 |  |  | $ | 92 |
General and administrative expenses |  |  | 3,299 |  |  |  | 1,299 |  |  |  | 1,196 |  |  |  | 270 |
|  | $ | 3,955 |  |  | $ | 1,872 |  |  | $ | 1,638 |  |  | $ | 362 |
Consultant restricted stock units [Member] |
Stockholders Equity Note [Line Items] |
Schedule of Unvested Restricted Stock Units |
|  | Number |
Unvested at the beginning of period |  |  | - |
Granted |  |  | 71,460 |
Forfeited |  |  | - |
Vested |  |  | (40,300 | )
Unvested at the end of the period |  |  | 31,160 |
Expected to vest after March 31, 2014 |  |  | 31,160 |
Schedule of Stock-based Compensation Expenses |
|  | Nine months ended March 31, |  |  | Three months ended March 31, |
|  | 2014 |  |  | 2013 |  |  | 2014 |  |  | 2013 |
Research and development expenses |  | $ | 59 |  |  | $ | 209 |  |  | $ | 42 |  |  | $ | 55 |
General and administrative expenses |  |  | 157 |  |  |  | 278 |  |  |  | 157 |  |  |  | - |
|  | $ | 216 |  |  | $ | 487 |  |  | $ | 199 |  |  | $ | 55 |

X
- Details
Name: | psti_StockholdersEquityNoteLineItems
Namespace Prefix: | psti_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration